A new article examining data from clinical trials led by Melissa Armstrong, M.D., an assistant professor of neurology, shows that nusinersen treatment benefits certain patients with spinal muscular atrophy.
A new discovery led by Dr. Catherine Flores using stem cells to overcome resistance to immunotherapy drugs may open the door to more effective treatment for brain cancer.
The seventh annual 2018 Celebrating Distinction event honored faculty named to endowed professorships, chairs.
Melissa Armstrong, M.D., an assistant professor of neurology, partnered with the Lewy Body Dementia Association to survey the families of patients who had dementia with Lewy bodies.
Addiction research led by Drs. Caitlin Orsini and Marcelo Febo, was recently chosen as a Research Highlight in the journal eNeuro.
Dear Colleagues, Please join us on Dec. 7 for our McKnight Brain Institute 20th Anniversary Celebration at the Cade Museum. The celebration will serve as this year’s holiday party and we look forward to this opportunity to thank you for your contributions to the MBI. We hope to see you…
Dr. Todd Golde and colleagues published a review in Nature Neuroscience highlighting the usefulness and limitations of using mouse models to study neurodegenerative diseases.
Duane Mitchell, M.D., Ph.D., co-director of the Preston A. Wells, Jr. Center for Brain Tumor Therapy, announced the UF Health-led Legacy Program in Brain Cancer at the Biden Cancer Summit.
Brain cancer experts at the MBI launch a new venture with institutions from across the nation and Canada.
Dr. Golde discussed neuromedicine research on campus — from Alzheimer's disease to age-related memory loss to brain cancer.
